Techniques: Crystal structure of myeloid leukemia cell differentiation protein (MCL1)

Drug platforms

TECHNOLOGY: Crystal structures

Crystallographic studies on an MCL1 fusion protein could aid the structure-based design of MCL1-specific inhibitors. A fusion of maltose binding protein

Read the full 244 word article

User Sign In